Gyre Therapeutics Aktie

Watchlist GYRE WKN A3EE5F ISIN US4037831033
- -
-

Was macht Gyre Therapeutics?

Unternehmensprofil
Unternehmensprofil

Gyre Therapeutics, Inc. operates as a biopharmaceutical company. It is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis). The firm operates through the BC and Gyre segments. The company was founded on March 7, 1997 and is headquartered in San Diego, CA.

Chart der Gyre Therapeutics Aktie

Charttool öffnen